Both in Pharmaceuticals
GT Biopharma vs Actuate Therapeutics
Over the past year GTBP returned −67.1% and ACTU returned −94.9%; their daily moves had a correlation of 0.08.
GTBP −67.1% ACTU −94.9%Growth of $1, one year, split-adjusted
| Metric | GTBP | ACTU |
|---|---|---|
| Price | $5.13 | $0.3420 |
| Market cap | $9.3M | $8.2M |
| Today | −3.57% | +2.06% |
| 1 month | −15.9% | −58.2% |
| 6 months | −46.4% | −88.4% |
| Year to date | −73.9% | −94.4% |
| 1 year | −67.3% | −94.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $5.0M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 958.2% | 161.3% |
| Short % of float | 24.1% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).